Why the Future of Cancer Early Detection Depends on Public-Private Partnerships
Publications
In this Article
Public-Private Partnerships are Key to Cancer Research
A cancer diagnosis not only brings personal adversity; it has ripple effects that impact businesses and contribute to collective challenges around battling the disease. This makes it more imperative than ever to quickly develop early cancer detection methods.
The article, co-authored by the PRECEDE Foundation and Azenta, and published in Business Insight Journal, covers how public-private partnerships can speed these efforts, allowing each partner to leverage their respective strengths for the other’s benefit.
What You’ll Learn
Collaborating on Cancer Research Efforts
This article introduces public-private partnerships as a new and competitive business model in pancreatic cancer early detection research that may work well applied to other research areas. It discusses overarching benefits such as:
- Scalable, rapid operations and logistics
- Reduced development risk
- Enhanced standardization and communication
Read about this compelling approach to cancer research efficiencies applied to pancreatic cancer early detection and a global sample management infrastructure!
